WordNet
- a synthetic type of penicillin antibiotic (trade name Pipracil) used for moderate to severe infections (同)Pipracil
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/06/07 01:22:45」(JST)
wiki en
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 成人における確定診断を得られていない低血圧やショックの評価および初期アプローチ evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock
- 2. βラクタム系抗生物質の長期注入投与 prolonged infusions of beta lactam antibiotics
- 3. β-ラクタマーゼ阻害剤、カルバペネム系、およびモノバクタム系抗菌薬の併用 combination beta lactamase inhibitors carbapenems and monobactams
- 4. 基質特異性拡張型β-ラクタマーゼ extended spectrum beta lactamases
- 5. 緑膿菌感染症に対する抗菌薬治療の原則 principles of antimicrobial therapy of pseudomonas aeruginosa infections
English Journal
- Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.
- Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, Durocher A.SourceIntensive Care Unit, Calmette Hospital, University Hospital of Lille, Lille ?Medical Assessment Laboratory, Lille II University, Lille ?Microbiology Laboratory, Biology and Pathology Centre, University Hospital of Lille, Lille, France.
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.Clin Microbiol Infect.2011 Aug;17(8):1201-8. doi: 10.1111/j.1469-0691.2010.03420.x. Epub 2010 Dec 13.
- Clin Microbiol Infect 2011; 17: 1201-1208 ABSTRACT: The objective of this prospective cohort study was to determine whether admission to an intensive care unit (ICU) room previously occupied by a patient with multidrug-resistant (MDR) Gram-negative bacilli (GNB) increases the risk of acquiring these
- PMID 21054665
- Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis.
- Johnson MT, Reichley R, Hoppe-Bauer J, Dunne WM, Micek S, Kollef M.SourceFrom the Department of Pharmacy Practice (MTJ), UIC-College of Pharmacy, Chicago, IL; the Hospital Informatics Group (RR), BJC Healthcare, St Louis, MO; the Laboratory Medicine Department (JH-B, WMD) and the Pharmacy Department, Barnes-Jewish Hospital (SM), St Louis, MO; and the Pulmonary and Critical Care Division (MK), Washington University School of Medicine, St Louis, MO.
- Critical care medicine.Crit Care Med.2011 Aug;39(8):1859-65.
- OBJECTIVE: : To determine whether exposure to antimicrobial agents in the previous 90 days resulted in decreased bacterial susceptibility and increased hospital mortality in patients with severe sepsis or septic shock attributed to Gram-negative bacteremia.DESIGN: : A retrospective cohort study of h
- PMID 21499086
Japanese Journal
- The activity of piperacillin/tazobactam : β-lactamases ; antibiograms and emerging pathogens
- LIVERMORE David M
- 日本化学療法学会雜誌 = Japanese journal of chemotherapy 56, 81, 2008-11-06
- NAID 10024455165
- The role of Piperacillin/Tazobactam ; NP, VAP and HCAP
- MANDELL Lionel
- 日本化学療法学会雜誌 = Japanese journal of chemotherapy 56, 74, 2008-11-06
- NAID 10024455158
Related Links
- Tazobactam / Piperacillin [TAZ / PIPC] タゾバクタム/ピペラシリン, ペニシリン系 1. 商品名 先発品 ゾシン静注用2.25／ゾシン静注用4.5 【大鵬薬品工業, 大正富山医薬品, 富山化学工業】 2. 日本における発売年 2001（平成13）年 ...
- Medscape - Indication-specific dosing for Zosyn, (piperacillin-tazobactam), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information. ... Cautions Risk of ...
Related Pictures
★リンクテーブル★
| リンク元 | 「ピペラシリン-タゾバクタム」 |
「ピペラシリン-タゾバクタム」
- 英
- piperacillin-tazobactam
- 商
- ゾシン Zosyn
- 関
- piperacillin-tazobactam、ピペラシリン piperacillin タゾバクタム tazobactam
参考
http://www.weblio.jp/content/%E3%83%94%E3%83%9A%E3%83%A9%E3%82%B7%E3%83%AA%E3%83%B3%E2%80%90%E3%82%BF%E3%82%BE%E3%83%90%E3%82%AF%E3%82%BF%E3%83%A0 http://www.labo-tech.co.jp/iyakuhin/koukinyaku_binran/num09/nm09_06.html